Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver MeetingĀ®
Stock Information for Arbutus Biopharma Corporation
Loading
Please wait while we load your information from QuoteMedia.